Determining Complement Binding Donor Specific HLA Antibody by Luminex Assay - Is It Clinically Relevant?

被引：0
|
作者：
Lunz, J. [1 ]
Webber, S. [1 ]
Soltys, K. [1 ]
Shapiro, R. [1 ]
Teuteberg, J. [1 ]
Feingold, B. [1 ]
Morrell, M. [1 ]
Jelinek, L. [1 ]
Zeevi, A. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1520
引用
收藏
页码：472 / 472
页数：1
相关论文
共 50 条
  • [41] THE PROBLEM OF HIGH BACKGROUND ON LUMINEX HLA ANTIBODY TESTING CAN BE VENDOR SPECIFIC
    Maccagno, Giancarlo
    Jung, Achim
    Carbol, Alexander
    Marandiuc, Dana
    Conradi, Roland
    Hitzler, Walter
    HLA, 2019, 93 (05) : 306 - 306
  • [42] THE ANTI-HUMAN GLOBULIN ENHANCED C1QSCREEN™ ASSAY IMPROVES THE DETECTION OF COMPLEMENT BINDING DONOR SPECIFIC HLA ANTIBODIES
    Liwski, Robert
    Lee, Sandra
    Sperry, Roxanne
    Nickerson, Peter
    Bray, Robert
    Gebel, Howard
    HUMAN IMMUNOLOGY, 2013, 74 : 48 - 48
  • [43] IS Clq BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODIES STILL CLINICALLY RELEVANT MORE THAN 10 YEARS AFTER KIDNEY TRANSPLANTATION?
    Calp-Inal, S.
    Colavai, A.
    Melamed, M.
    Akalin, E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A35 - A35
  • [44] Comparison of complement-dependent cytotoxicity and Luminex methodology for anti-HLA antibody screening
    Pereira, L.
    Castelane, F.
    Pereira, E.
    Yamakawa, R.
    Saito, P.
    Borelli, S.
    TISSUE ANTIGENS, 2008, 72 (03): : 257 - 257
  • [45] COMPLEMENT (C′)-BINDING ANTI-HLA DONOR SPECIFIC ANTIBODIES (DSA) IN HEART TRANSPLANTATION. CORRELATION WITH ANTIBODY MEDIATED REJECTION (AMR)
    Redonnet, M.
    Belin, A.
    Hau, F.
    Toutirais, O.
    Quelvennec, E.
    Le Mauf, B.
    Francois, A.
    Crahes, M.
    Galateau, M.
    Nafeh, C.
    Gay, A.
    Blanchart, K.
    Babtasi, G.
    Litzler, P. Y.
    Bessou, J. P.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 2 - 2
  • [46] IMPACT OF PREFORMED ANTI-HLA DONOR SPECIFIC ANTIBODIES DETECTED BY SINGLE ANTIGEN LUMINEX ASSAY ON KIDNEY TRANSPLANTS PERFORMED WITH NEGATIVE COMPLEMENT DEPENDENT CYTOTOXICITY T AND B CROSSMATCHES
    Holanda-Cavalcanti, Alexandre
    Campos, Erika F.
    Grenzi, Patricia C.
    de Marco, Renato
    Rampim, Gisele
    Tedesco-Silva, Helio
    Medina-Pestana, Jose O.
    Gerbase-DeLima, Maria
    TISSUE ANTIGENS, 2012, 79 (06): : 511 - 511
  • [47] The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera
    Weinstock, C.
    Schnaidt, M.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2013, 40 (03) : 171 - 177
  • [48] Importance of the nature and binding specificity of the secondary antibody used in Luminex single antigen bead assays for monitoring clinically relevant HLA IgG antibodies in pre- and post-transplant patients
    Ravindranath, Mepur H.
    Jucaud, Vadim
    Banuelos, Nubia
    Anh Nguyen
    Everly, Mathew
    Cai, Junchao
    Terasaki, Paul I.
    TRANSPLANTATION, 2016, 100 (07) : S375 - S376
  • [49] Are All Donor-Specific Antibodies Detected by Solid-Phase Assay Before Transplantation Clinically Relevant?
    Aubert, Vincent
    Venetz, Jean-Pierre
    Pantaleo, Giuseppe
    Pascual, Manuel
    TRANSPLANTATION, 2009, 87 (12) : 1897 - 1898
  • [50] ARE DONOR SPECIFIC HLA ANTIBODIES DETECTED BY LUMINEX PREDICTIVE OF POSITIVE FLOW CYTOMETRIC CROSSMATCH?
    Aubert, Vincent
    Sugamele, Rocco
    Gregoretti, Stephanie
    Venetz, Jean-Pierre
    Pantaleo, Giuseppe
    Pascual, Manuel
    TISSUE ANTIGENS, 2015, 85 (05): : 415 - 415
12345